Kostakoglu L - Search Results

1

Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.

Elliott BM, Peti S, Osman K, Scigliano E, Lee D, Isola L, Kostakoglu L. Elliott BM, et al. Among authors: kostakoglu l. Eur J Haematol. 2011 Apr;86(4):289-98. doi: 10.1111/j.1600-0609.2010.01575.x. Epub 2011 Feb 1. Eur J Haematol. 2011. PMID: 21198866

2

Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).

Cameron K, Golan S, Simpson W, Peti S, Roayaie S, Labow D, Kostakoglu L. Cameron K, et al. Among authors: kostakoglu l. Abdom Imaging. 2011 Aug;36(4):463-71. doi: 10.1007/s00261-011-9729-6. Abdom Imaging. 2011. PMID: 21465110 Review.

3

FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.

Chu MM, Kositwattanarerk A, Lee DJ, Makkar JS, Genden EM, Kao J, Packer SH, Som PM, Kostakoglu L. Chu MM, et al. Among authors: kostakoglu l. Radiographics. 2010 Sep;30(5):1353-72. doi: 10.1148/rg.305095764. Radiographics. 2010. PMID: 20833855

4

Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan.

Simpson WL Jr, Lee KM, Sosa N, Cooper N, Scigliano E, Brody JD, Doucette JT, Kostakoglu L. Simpson WL Jr, et al. Among authors: kostakoglu l. Leuk Lymphoma. 2016 May;57(5):1083-93. doi: 10.3109/10428194.2015.1089437. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26422408

5

State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.

Mesguich C, Fardanesh R, Tanenbaum L, Chari A, Jagannath S, Kostakoglu L. Mesguich C, et al. Among authors: kostakoglu l. Eur J Radiol. 2014 Dec;83(12):2203-2223. doi: 10.1016/j.ejrad.2014.09.012. Epub 2014 Sep 28. Eur J Radiol. 2014. PMID: 25308249 Review.

6

Role of FDG PET/CT in staging of recurrent ovarian cancer.

Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L, Machac J, Heiba S, Kostakoglu L. Son H, et al. Among authors: kostakoglu l. Radiographics. 2011 Mar-Apr;31(2):569-83. doi: 10.1148/rg.312105713. Radiographics. 2011. PMID: 21415197 Review.

7

Current role of FDG PET/CT in lymphoma.

Kostakoglu L, Cheson BD. Kostakoglu L, et al. Eur J Nucl Med Mol Imaging. 2014 May;41(5):1004-27. doi: 10.1007/s00259-013-2686-2. Epub 2014 Feb 12. Eur J Nucl Med Mol Imaging. 2014. PMID: 24519556 Review.

8

FDG-PET lymphoma demonstration project invitational workshop.

Kelloff GJ, Sullivan DM, Wilson W, Cheson B, Juweid M, Mills GQ, Zelenetz AD, Horning SJ, Weber W, Sargent DJ, Dodd L, Korn E, Armitage J, Schilsky R, Christian M, O'connor OA, Wang SJ, Farrell AT, Pazdur R, Graham M, Wahl RL, Larson SM, Kostakoglu L, Daube-Witherspoon M, Gastonis C, Siegel BA, Shankar LK, Lee DB, Higley HR, Sigman CC, Carucci D, Timko D, deGennaro LJ, Sigal E, Barker A, Woodcock J. Kelloff GJ, et al. Among authors: kostakoglu l. Acad Radiol. 2007 Mar;14(3):330-9. doi: 10.1016/j.acra.2006.12.003. Acad Radiol. 2007. PMID: 17307666

9

PET/CT evaluation of cervical cancer: spectrum of disease.

Son H, Kositwattanarerk A, Hayes MP, Chuang L, Rahaman J, Heiba S, Machac J, Zakashansky K, Kostakoglu L. Son H, et al. Among authors: kostakoglu l. Radiographics. 2010 Sep;30(5):1251-68. doi: 10.1148/rg.305105703. Radiographics. 2010. PMID: 20833849

10

Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting.

King KG, Kositwattanarerk A, Genden E, Kao J, Som PM, Kostakoglu L. King KG, et al. Among authors: kostakoglu l. Radiographics. 2011 Mar-Apr;31(2):355-73. doi: 10.1148/rg.312095765. Radiographics. 2011. PMID: 21415184 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page